Skip to main content

CORRECTION article

Front. Immunol., 13 November 2024
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1518823

Corrigendum: A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers

This article is a correction to:

  1. A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers

    1. Read original article
Wenqian Zhang,,&#x;Wenqian Zhang1,2,3†Jiewen Fu&#x;Jiewen Fu1†Jiaman Du&#x;Jiaman Du1†Xiaoyan LiuXiaoyan Liu1Jingliang ChengJingliang Cheng1Chunli WeiChunli Wei1Youhua Xu*Youhua Xu3*Junjiang Fu,*Junjiang Fu1,3*
  • 1Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, Sichuan, China
  • 2Department of Rehabilitation Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China
  • 3State Key Laboratory of Quality Research in Chinese Medicine, Faculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macau SAR, China

A Corrigendum on
A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers

By Zhang W, Fu J, Du J, Liu X, Cheng J, Wei C, Xu Y and Fu J (2024). Front. Immunol. 15:1434027. doi: 10.3389/fimmu.2024.1434027

In the published article, there was an error in affiliation(s) Youhua Xu1,*. Instead of “Youhua Xu 1,*”, it should be “Youhua Xu 3,*”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: ADAM10, expression, pan-cancer, immunotherapy, adenosine, CD, m62A

Citation: Zhang W, Fu J, Du J, Liu X, Cheng J, Wei C, Xu Y and Fu J (2024) Corrigendum: A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers. Front. Immunol. 15:1518823. doi: 10.3389/fimmu.2024.1518823

Received: 29 October 2024; Accepted: 30 October 2024;
Published: 13 November 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Zhang, Fu, Du, Liu, Cheng, Wei, Xu and Fu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Junjiang Fu, fujunjiang@swmu.edu.cn; fujunjiang@hotmail.com; Youhua Xu, yhxu@must.edu.mo

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.